INVL Logo

Sanitas AB forecasts for 2008

On December 12, 2007 Management Board of Sanitas AB approved activity forecasts of Sanitas AB group for 2008. It is expected to have sales totaling to LTL 393.7 m. (€..

More

Vilniaus baldai AB turnover during period of January –...

Turnover of Vilniaus baldai AB during November 2007 was 10743 thousand Litas (3 111 thousand EUR), November of previous year – 9 570 thousand Litas (2 772 thousand EUR). November..

More

Vilniaus baldai AB activity results during period of January...

Net profit of Vilniaus baldai AB during October 2007 was 345 thousand LTL (100 thousand EUR), October of previous year – net losses 742 thousand LTL (215 thousand EUR).EBITDA during October..

More

Vilniaus baldai AB turnover during period January –...

Turnover of Vilniaus baldai AB during October 2007 was 15 227 thousand LTL (4 410 thousand EUR), October of previous year – 9 759 thousand LTL (2 826 thousand EUR). During period..

More

Vilniaus baldai AB results of September 2007

Net profit of AB „Vilniaus baldai“ during September 2007 was 174 thousand LTL (51 thousand EUR), September of previous year – net loss of 607 thousand LTL (176 thousand EUR). EBITDA..

More

Invalda AB: Signing of Protocol of Intent

Today Finasta investicijų valdymas UAB and PZU Lietuva gyvybes draudimas UAB signed the Protocol of Intent regarding transference of rights and obligations of the pension funds‘ participants. Finasta investicijų valdymas..

More

Net result of Vilniaus Baldai for the period of January-May...

Net profit of AB „Vilniaus baldai“ during May 2007 was 148 tLTL (43 tEUR),  and during May of previous year it totaled 119 tLTL (34 tEUR).  EBITDA during May 2007 was..

More

Preliminary result of Sanitas group for May, 2007

Preliminary consolidated result of Sanitas Group activity for May 2007 is net profit of  LTL 7.06 m. (€ 2.05 m.), EBITDA is LTL 13.45 m. (€ 3.89 m.).

More

“Sanitas” takes over management of modern pharmaceutical...

The largest Lithuanian pharmaceutical company “Sanitas” took over the control of purchased Slovak pharmaceutical plant “Hoechst-Biotika” today. The purchase price is LTL 43.85 mln. “The settlement with the sellers of “Hoechst-Biotika” went..

More